Table 1 Patients undergoing trans-scleral Essen biopsies (TSEB).
From: Posterior uveal biopsy and the trans-scleral Essen forceps biopsy technique
Variable | N (%) | |
|---|---|---|
Mean Age | 66 (range 50–88) | - |
Gender | Male | 10 (91) |
Female | 1 (9) | |
Laterality | Right | 8 (73) |
Left | 3 (27) | |
Lesion Location | Temporal | 3 (27.5) |
Inferotemporal | 3 (27.5) | |
Inferior | 1 (9) | |
Inferonasal | 1 (9) | |
Nasal | 1 (9) | |
Superonasal | 1 (9) | |
Superior | 1 (9) | |
Anterior or Posterior | Anterior | 8 (73) |
Posterior | 3 (27) | |
Uveal location | Choroid | 9 (82) |
Ciliary Body | 2 (18) | |
Mean Lesion Thickness (mm) | 4.9 (range 1.4–11.2) | - |
Mean Lesion Diameter (mm) | 13.9 (range 6.3–22.8) | - |
Biopsy result | Choroidal/ciliary body melanoma | 6 (54) |
Choroidal melanocytoma | 1 (9) | |
Inconclusive | 2 (18) | |
Contaminants only | 1 (9) | |
ENMZ Lymphoma | 1 (9) | |
Success rate | Total | 8 (73) |
Treatment | Observation | 1 (9) |
Plaque Brachytherapy | 4 (36.5) | |
External Beam Radiotherapy | 1 (9) | |
Enucleation | 4 (36.5) | |
Proton Beam | 1 (9) | |
Complications | Vitreous Loss | 1 (9) |
None | 10 (91) | |
